1. Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck
- Author
-
Yoichi Sakata, Takashi Ishida, Toyotoshi Yasuda, Ken Kitamura, and Mamoru Morita
- Subjects
Pathology ,medicine.medical_specialty ,Maxillary Sinus Neoplasms ,Tissue plasminogen activator ,Metastasis ,chemistry.chemical_compound ,Plasminogen Activator Inhibitor 1 ,medicine ,Humans ,Vitronectin ,Laryngeal Neoplasms ,Neoplasm Staging ,biology ,Activator (genetics) ,business.industry ,Pharyngeal Neoplasms ,medicine.disease ,Primary tumor ,Immunohistochemistry ,Urokinase-Type Plasminogen Activator ,Tongue Neoplasms ,Otorhinolaryngology ,chemistry ,Epidermoid carcinoma ,Head and Neck Neoplasms ,Plasminogen activator inhibitor-1 ,Lymphatic Metastasis ,Tissue Plasminogen Activator ,biology.protein ,Carcinoma, Squamous Cell ,business ,Plasminogen activator ,medicine.drug - Abstract
Background Plasminogen activators (PAs) and their inhibitors are thought to play an important role in tumor invasion and metastasis. However, there have been few reports in which histologic localization of PAs has been demonstrated in head and neck tumors. Methods We examined the patterns of expression of urokinase-type plasminogen activator (u-PA), tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor 1 (PAI-1), and vitronectin in head and neck squamous cell carcinomas using immunohistochemical techniques. We also studied the correlation between the immunohistologic expression of these fibrinolytic proteins and the clinical staging of the tumor. Results Of 28 tumor specimens, 15 (54%) showed immunoreactivity for u-PA; 8 (36%), for t-PA; and 23 ( 82%), for PAI-1. There was a significant correlation between PAI-1 expression and the extent of the primary tumor. Conclusions The present study demonstrates the existence and possible pathophysiologic significance of u-PA and PAI-1 in squamous cell carcinomas of the head and neck. © 1997 John Wiley & Sons, Inc. Head Neck19: 611–616, 1997.
- Published
- 1997